Diagnosis and Management of Pancreatic Cancer

Introduction to Diagnostic Principles

The National Comprehensive Cancer Network recommends that patients with resectable pancreatic cancer should undergo surgical resection without preoperative tissue diagnosis if they are good surgical candidates 1, 2, 3
For patients with potentially resectable lesions, surgical resection should be performed without preoperative tissue diagnosis, as the risk of benign disease is acceptable if the procedure is done with low morbidity and mortality 1, 4, 5
A negative biopsy result should not delay surgical resection when there is a high clinical suspicion of pancreatic cancer 2, 3

EUS-guided fine needle aspiration (EUS-FNA) is the preferred method for obtaining a tissue diagnosis in pancreatic cancer 2, 3, 5
EUS-FNA is preferred over percutaneous biopsy due to its higher diagnostic yield, better safety profile, and lower risk of peritoneal seeding 2, 3
The sensitivity of EUS-FNA for pancreatic masses is 70-85% 6

Laparoscopic staging can identify peritoneal, capsular, and liver metastases that may be missed on CT or MRI scans 2, 3
Laparoscopy can avoid unnecessary laparotomy in approximately 23% of patients planned for curative surgery 2, 3
Laparoscopy should be considered for patients with resectable pancreatic cancer who are at high risk for disseminated disease (e.g., very high CA 19-9 levels) 2, 3

For resectable disease, CT multiphasic or MRI with pancreatic protocol should be performed for staging 6, 8
Laparoscopy staging should be considered if CA 19-9 is high or the tumor is large 2, 3
Surgical resection should be performed without biopsy if there are no metastases 1, 4, 5, 6
Resection should be performed at a high-volume center (15-20 pancreatic resections per year) 6, 8

Diagnostic laparotomy should not be performed solely for biopsy in pancreatic cancer 1, 6
Failure to obtain histological confirmation does not rule out malignancy and should not delay appropriate surgical treatment in highly suspicious cases 1, 7
Preoperative percutaneous sampling should be avoided in candidates for surgery with potentially resectable lesions 4, 7